1. Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer <scp>A549</scp> cells in vitro
- Author
-
Xun Qu, Handai Xia, Jing Qin, Yawei Wang, Yanguo Liu, Xiuwen Wang, Wenjuan Gao, and Wenfei Han
- Subjects
non‐small cell lung cancer ,Adult ,Male ,Pulmonary and Respiratory Medicine ,Lung Neoplasms ,Antineoplastic Agents, Hormonal ,Paclitaxel ,medicine.medical_treatment ,Mice, Nude ,Apoptosis ,Octreotide ,Targeted therapy ,Mice ,chemistry.chemical_compound ,Carcinoma, Non-Small-Cell Lung ,medicine ,Animals ,Humans ,Cytotoxic T cell ,Somatostatin receptor 2 ,cytotoxic analogs ,Receptors, Somatostatin ,RC254-282 ,Aged ,Cell Proliferation ,A549 cell ,Chemotherapy ,Somatostatin receptor ,business.industry ,Cell Cycle ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Original Articles ,General Medicine ,Middle Aged ,Antineoplastic Agents, Phytogenic ,paclitaxel resistance ,Oncology ,chemistry ,A549 Cells ,Drug Resistance, Neoplasm ,somatostatin receptors ,Cancer cell ,Cancer research ,Original Article ,Female ,business - Abstract
The application of chemotherapy in non‐small cell lung cancer (NSCLC) is limited by the toxicity to normal cells and the development of multi‐drug resistance. Targeted chemotherapy using cytotoxic analogs against specific receptors on cancer cells could be a less toxic and more efficacious approach. We identified that the expressions of somatostatin receptor (SSTR) 2 and 5 in tumor tissues from NSCLC patients were higher than those in the adjacent normal tissues by immunohistochemistry, and therefore, cytotoxic somatostatin analogues might be applied for SSTRs‐mediated targeted therapy against NSCLC. Two cytotoxic analogs, paclitaxel‐octreotide (PTX‐OCT) and 2paclitaxel‐octreotide (2PTX‐OCT), were synthesized by linking one or two molecules of paclitaxel to one molecule of somatostatin analog octreotide. PTX‐OCT and 2PTX‐OCT significantly inhibited the growth and induced apoptosis of SSTR2‐ and SSTR5‐positive A549 cells, compared with the control (p, Targeted cytotoxic somatostatin analogs paclitaxel‐octreotide (PTX‐OCT) conjugates inhibited the growth and induced apoptosis of A549 cells in a SSTRs‐mediated manner, whereas they were less toxic to H157 (SSTRs‐negative) cells. PTX‐OCT and PTX‐2OCT significantly reverse paclitaxel resistance, with no or lower induction of MDR genes such as MDR‐1, MRP‐1, and BCRP than paclitaxel in vitro.
- Published
- 2021
- Full Text
- View/download PDF